The successful derivation of human induced pluripotent stem cells (hiPSCs) from somatic cells offers significant potential to overcome obstacles in the field of cardiovascular disease. hiPSC-derived cardiac cells can now provide incredible potential for disease modeling in vitro and regenerative medicine therapies in vivo. Recently, several exciting demonstrations of the disease modeling capability of hiPSC- derived cardiac cells have been published (e.g., Timothy syndrome, LEOPARD syndrome). These patient-specific hiPSC-CMs have been found to recapitulate the disease phenotypes. In contrast to Timothy and LEOPARD syndrome (which are considered orphan diseases), familial dilated cardiomyopathy (DCM) is the most common cause of heart failure and hence places a tremendous burden on the healthcare system in the US and worldwide. Here we seek to derive hiPSCs from patients with familial dilated cardiomyopathy (Aim 1), determine the phenotype of hiPSC-cardiac cells from DCM patients versus healthy controls (Aim 2), and evaluate their functionality after genetic rescue using homologous recombination (Aim 3). We believe the findings here should have broad clinical and scientific impact toward better understanding on the molecular and cellular basis of DCM.
Familial dilated cardiomyopathy (DCM) is the most common cause of heart failure and places a tremendous burden on the healthcare system in the US and worldwide. From the early beginnings of the genomic era and since the description of the first familial DCM causing mutations, investigators have attempted to study its mechanistic basis by correlating genotype with clinical phenotype expression. Unfortunately, these studies have been severely hampered by the inaccessibility of human cardiomyocytes. In this grant proposal, we will generate human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from patients with DCM. We will perform detailed and mechanistic analyses to determine the functional and molecular phenotypes of DCM. This approach will dramatically enhance our ability to perform future high-throughput drug screening, evaluate gene and cell therapies, and assess potential novel therapies of DCM.
|Matsa, Elena; Burridge, Paul W; Yu, Kun-Hsing et al. (2016) Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses InÂ Vitro. Cell Stem Cell 19:311-25|
|Riegler, Johannes; Ebert, Antje; Qin, Xulei et al. (2016) Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas. Stem Cell Reports 6:176-87|
|Burridge, Paul W; Diecke, Sebastian; Matsa, Elena et al. (2016) Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes. Methods Mol Biol 1353:119-30|
|Hu, Shijun; Zhao, Ming-Tao; Jahanbani, Fereshteh et al. (2016) Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. JCI Insight 1:|
|Kodo, Kazuki; Ong, Sang-Ging; Jahanbani, Fereshteh et al. (2016) iPSC-derived cardiomyocytes reveal abnormal TGF-Î² signalling in left ventricular non-compaction cardiomyopathy. Nat Cell Biol 18:1031-42|
|Dewey, Frederick E; Grove, Megan E; Priest, James R et al. (2015) Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data. PLoS Genet 11:e1005496|
|Gu, Mingxia; Mordwinkin, Nicholas M; Kooreman, Nigel G et al. (2015) Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. Eur Heart J 36:806-16|
|Diecke, Sebastian; Lu, Jiamiao; Lee, Jaecheol et al. (2015) Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency. Sci Rep 5:8081|
|Nejadnik, Hossein; Diecke, Sebastian; Lenkov, Olga D et al. (2015) Improved approach for chondrogenic differentiation of human induced pluripotent stem cells. Stem Cell Rev 11:242-53|
|Wu, Haodi; Lee, Jaecheol; Vincent, Ludovic G et al. (2015) Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised Î²-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. Cell Stem Cell 17:89-100|
Showing the most recent 10 out of 50 publications